| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics, Inc. | Director | Common Stock | 62,416 | $204,724 | $3.28 | 12 Jan 2026 | By WaterMill Asset Management Corp. |
| Alaunos Therapeutics, Inc. | Director | Common Stock | 43,872 | $126,790 | $2.89 | 12 Jan 2026 | Direct |
| Alaunos Therapeutics, Inc. | Director | Series A-2 Convertible Preferred Stock | 600 | $2,694 | $4.49 | 24 Jun 2025 | By Watermill Asset Management Corp |
| Alaunos Therapeutics, Inc. | Director | Series A-1 Convertible Preferred Stock | 500 | $1,380 | $2.76 | 11 Apr 2025 | By WaterMill Asset Management Corp. |
| Alaunos Therapeutics, Inc. | Director | Common Stock | 24 | $78 | $3.28 | 12 Jan 2026 | By spouse's IRA |
| Alaunos Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 6,400 | 03 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TCRT | Alaunos Therapeutics, Inc. | 12 Jan 2026 | 1 | +$16,248 | 4 | Director | 15 Jan 2026, 16:15 |
| TCRT | Alaunos Therapeutics, Inc. | 21 Nov 2025 | 1 | +$16,249 | 4 | Director | 26 Nov 2025, 21:26 |
| TCRT | Alaunos Therapeutics, Inc. | 03 Jul 2025 | 2 | $0 | 4 | Director | 07 Jul 2025, 19:11 |
| TCRT | Alaunos Therapeutics, Inc. | 24 Jun 2025 | 3 | +$64,822 | 4 | Director | 26 Jun 2025, 21:19 |
| TCRT | Alaunos Therapeutics, Inc. | 11 Apr 2025 | 2 | +$62,128 | 4 | Director | 15 Apr 2025, 20:42 |
| TCRT | Alaunos Therapeutics, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 17:00 |
| TCRT | Alaunos Therapeutics, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 17:27 |
| TCRT | Alaunos Therapeutics, Inc. | 29 Nov 2022 | 1 | +$487,500 | 4 | Director | 01 Dec 2022, 15:05 |
| TCRT | Alaunos Therapeutics, Inc. | 22 Jun 2022 | 2 | $0 | 4 | Director | 24 Jun 2022, 16:35 |
| TCRT | Alaunos Therapeutics, Inc. | 22 Jun 2022 | 2 | $0 | 4 | Director | 24 Jun 2022, 16:31 |
| TCRT | ZIOPHARM ONCOLOGY INC | 02 Sep 2021 | 2 | +$129,750 | 4 | Director | 03 Sep 2021, 17:22 |